Literature DB >> 14550272

Binding characteristics of SSR180575, a potent and selective peripheral benzodiazepine ligand.

V Vin1, N Leducq, F Bono, J M Herbert.   

Abstract

The peripheral benzodiazepine receptor (PBR), has been recently shown to play a key role in the regulation of the mitochondrial process leading to apoptosis, which occurs during cardiac ischemia. The present work shows that SSR180575, a novel PBR ligand of potential interest in pathological cardiovascular indications, irreversibly and specifically binds with high affinity on both rat heart mitochondria and on a cell line transfected with the human PBR (K(d)=1.95+/-0.22 and 4.58+/-0.83nM, respectively). In conclusion, SSR180575 is a specific and potent PBR ligand which irreversible binding to PBR appears of high interest in various therapeutic indications where apoptosis occurs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14550272     DOI: 10.1016/j.bbrc.2003.09.079

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Molecular imaging of the translocator protein (TSPO) in a pre-clinical model of breast cancer.

Authors:  Shelby K Wyatt; H Charles Manning; Mingfeng Bai; Stephanie N Bailey; Pascal Gallant; Guobin Ma; Laura McIntosh; Darryl J Bornhop
Journal:  Mol Imaging Biol       Date:  2009-12-01       Impact factor: 3.488

2.  The development of mitochondrial membrane affinity chromatography columns for the study of mitochondrial transmembrane proteins.

Authors:  K-L Habicht; N S Singh; F E Indig; I W Wainer; R Moaddel; R Shimmo
Journal:  Anal Biochem       Date:  2015-06-04       Impact factor: 3.365

3.  In vivo imaging of neuroinflammation in the rodent brain with [11C]SSR180575, a novel indoleacetamide radioligand of the translocator protein (18 kDa).

Authors:  Fabien Chauveau; Hervé Boutin; Nadja Van Camp; Cyrille Thominiaux; Philippe Hantraye; Luc Rivron; Frank Marguet; Marie-Noëlle Castel; Thomas Rooney; Jesus Benavides; Frédéric Dollé; Bertrand Tavitian
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-10-09       Impact factor: 9.236

Review 4.  Targeting neuroprotection as an alternative approach to preventing and treating neuropathic pain.

Authors:  Thierry Bordet; Rebecca M Pruss
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

5.  Facile synthesis of SSR180575 and discovery of 7-chloro-N,N,5-trimethyl-4-oxo-3(6-[(18)F]fluoropyridin-2-yl)-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide, a potent pyridazinoindole ligand for PET imaging of TSPO in cancer.

Authors:  Yiu-Yin Cheung; Michael L Nickels; Dewei Tang; Jason R Buck; H Charles Manning
Journal:  Bioorg Med Chem Lett       Date:  2014-08-08       Impact factor: 2.823

6.  Discovery of hydrazide-based pyridazino[4,5-b]indole scaffold as a new phosphoinositide 3-kinase (PI3K) inhibitor for breast cancer therapy.

Authors:  Ahmed A M Sarhan; Ahmed T A Boraei; Assem Barakat; Mohamed S Nafie
Journal:  RSC Adv       Date:  2020-05-21       Impact factor: 4.036

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.